周一盘中，中国生物制药（01177）股价突然飙升，涨幅高达5.03%，引起市场广泛关注。这一显著涨幅可能与近期南向资金的持续流入有关。
据最新数据显示，4月11日南向资金增持中国生物制药1401.80万股，截至当日收盘，港股通共持有该公司249502.26万股，占流通股的13.29%。这表明投资者对中国生物制药的信心正在增强。值得注意的是，在过去20个交易日里，该股已累计上涨3.17%，同期港股通累计增持17221.52万股，显示出持续的买入兴趣。
尽管中国生物制药在近5个交易日曾出现7.97%的跌幅，但南向资金仍保持积极态度，累计增持9232.20万股。这种逆势加仓的行为可能暗示一些机构投资者看好该公司的长期发展前景。在当前生物医药行业整体表现活跃的背景下，中国生物制药作为行业龙头企业之一，其股价的强劲表现也反映了市场对中国医药产业未来发展的乐观预期。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.